OI
JAZZ icon

Oakbrook Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Oakbrook Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,900
Closed -$413K – 623
2019
Q2 		$413K Buy
2,900
+1,400
+93% +$188K 0.02% 431
2019
Q1 		$214K Buy
+1,500
New +$196K 0.01% 573
2018
Q4 		– Sell
-1,800
Closed -$303K – 618
2018
Q3 		$303K Buy
+1,800
New +$310K 0.02% 545

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Oakbrook Investments's JAZZ Position: Q3 2019 in Review

Oakbrook Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 2,900 shares — an estimated $413K sold.

Oakbrook Investments first reported a position in JAZZ in Q3 2018 and held it in 3 quarters. The position peaked at $413K in Q2 2019. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Oakbrook Investments reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Oakbrook Investments sold 2,900 Jazz Pharmaceuticals shares in Q3 2019, an estimated $413K.
  • Oakbrook Investments first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Oakbrook Investments's Jazz Pharmaceuticals position peaked at $413K in Q2 2019.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Oakbrook Investments's 13F filing for Q3 2019, filed 18 Oct 2019.